<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03187522</url>
  </required_header>
  <id_info>
    <org_study_id>IP-0020-16</org_study_id>
    <nct_id>NCT03187522</nct_id>
  </id_info>
  <brief_title>An European Union (EU) Post-Approval Registry of the TREO® Stent-Graft</brief_title>
  <official_title>An EU Post-Approval Registry of the TREO® Stent-Graft for Patients With Infrarenal Abdominal Aortic Aneurysms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bolton Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bolton Medical Espana SLU</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bolton Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is an EU sponsored trial and independent of the US trial registered under
      Clinicaltrials.gov ID NCT02009644.

      The purpose of this registry is to gather clinical data on the safety and performance of the
      TREO Stent-Graft in patients with infrarenal abdominal aortic aneurysms. The registry is part
      of TREO's EU post-market surveillance plan providing long-term systematic clinical follow-up.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multicenter, post-market clinical follow-up, non-randomized registry
      of the TREO Stent-Graft. Subjects diagnosed with infrarenal aortic aneurysms and treated with
      the TREO Stent-Graft or TREO aorto-uni-iliac (AUI) device can be included into the registry.
      Pre-procedure baseline data will be gathered as well as post-procedure assessments prior to
      hospital discharge and one to three months and 1, 2, 3, 4, and 5-year post-implantation.

      The objective of the registry is to assess the clinical results and health economics of the
      TREO device in a real-world population of patients with infrarenal abdominal aortic aneurysms
      (AAA).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 22, 2017</start_date>
  <completion_date type="Anticipated">February 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This is a prospective, multi-center, post-market clinical follow-up, non-randomized registry of patients treated with the TREO stent-graft</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aneurysm-related mortality</measure>
    <time_frame>30 days post-procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Stroke (excluding transient ischemic attack)</measure>
    <time_frame>30 days post-procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>Raised cardiac enzymes within 30 days of the procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Renal failure</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>Renal failure requiring renal replacement therapy (excluding renal insufficiency)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Respiratory failure</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>excluding chronic obstructive pulmonary disease or pulmonary complications)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Paraplegia</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>(excluding paraparesis)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bowel ischemia</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>A restriction in blood supply to tissues in the bowels</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Treated aneurysm rupture</measure>
    <time_frame>30 days post-procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Events (MAE) at the follow-up time points</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>MAE includes any of the following : Aneurysm-related mortality, Stroke (excluding transient ischemic attack), Myocardial infarction, Renal failure requiring renal replacement therapy (excluding renal insufficiency), Respiratory failure (excluding chronic obstructive pulmonary disease or pulmonary complications), Paraplegia (excluding paraparesis), Bowel ischemia, Treated aneurysm rupture</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Limb Ischemia</measure>
    <time_frame>30 days post-procedure</time_frame>
    <description>Rate of clinically-evident ischemia, subcategorized by embolism or thrombosis, tabulated by the frequency of major amputation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Secondary procedures</measure>
    <time_frame>5 years</time_frame>
    <description>Freedom from aneurysm-related secondary procedures through five years follow-up. A questionnaire will be conducted. Investigators are required to conduct a lesion and device assessment at each follow-up visit. All secondary procedures reported will be treated descriptively in terms of results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular access complications</measure>
    <time_frame>Vascular access will be evaluated on day of index procedure (implant)</time_frame>
    <description>Injuries to vessels as a result of the endovascular procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported quality of life (QOL)</measure>
    <time_frame>One year follow-up</time_frame>
    <description>Health outcomes using the EuroQol Five Dimensions Questionnaire (EQ-5D) standardized EuroQol instrument.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Aortic Aneurysm, Abdominal</condition>
  <arm_group>
    <arm_group_label>TREO Stent-Graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients who receive a TREO Abdominal Stent-Graft System</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TREO Stent-Graft System</intervention_name>
    <description>The TREO® Stent-Graft is designed for use in the management of patients with AAAs and is composed of self-expanding nitinol stents sutured to polyester vascular graft fabric.</description>
    <arm_group_label>TREO Stent-Graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Signed informed consent

          -  Willingness to comply with study follow-up

          -  Indication for elective endovascular repair

          -  Planned implantation of single Treo device system or aorto uni-iliac (AUI) device to
             include any auxiliary device components

        Exclusion Criteria:

          -  Intolerance to contrast media

          -  Emergency procedure

          -  Chimneys or fenestrated device procedures

          -  Connective tissue disease (e.g., Marfan's syndrome)

          -  High probability of non-adherence to follow-up requirements

          -  Current participation in a concurrent trial that may confound study results

          -  Female of childbearing potential in whom pregnancy cannot be excluded

          -  Previous endovascular or surgical AAA repair
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Giovanni Torsello, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Center of Vascular and Endovascular Surgery, Munster University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lea Doyle</last_name>
    <phone>3523621021</phone>
    <email>LDoyle@BoltonMedical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Imelda Hospital</name>
      <address>
        <city>Bonheiden</city>
        <zip>2820</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Peeters</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Imeldaziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>AZ Sint Blasius</name>
      <address>
        <city>Dendermonde</city>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Bonifatius Hospital</name>
      <address>
        <city>Lingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>University Clinic and St. Franziskus Hospital Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>D-48145</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Giovanni Torsello, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Tübingen</name>
      <address>
        <city>Tübingen</city>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Compensorio Sanitario Bolzano</name>
      <address>
        <city>Bolzano</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMC Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>UMCU</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Clinic Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Vincent Riambau</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Complexo Hospitalario Universitario de Ourense</name>
      <address>
        <city>Ourense</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centro Vascolare Ticino, Ospedale Regionale di Lugano</name>
      <address>
        <city>Lugano</city>
        <zip>6903</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jos van den Berg</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Civico, Ospedale Regionale</name>
      <address>
        <city>Lugano</city>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Addenbrooke's Hospital, Cambridge University Hospitals</name>
      <address>
        <city>Cambridge</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary, Central Manchester University Hospitals</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital, Oxford University Hospitals</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Spain</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 11, 2017</study_first_submitted>
  <study_first_submitted_qc>June 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <last_update_submitted>January 9, 2018</last_update_submitted>
  <last_update_submitted_qc>January 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>AAA</keyword>
  <keyword>Abdominal Aortic Aneurysms</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

